Cardinal Health Latest News

Advanced Therapy Connect is a simplified ordering and reporting process for cell and gene therapy products

DUBLIN, Ohio, January. 17, 2025 – Cardinal Health (NYSE: CAH) today announced the launch of Advanced Therapy Connect, a best-in-market unified ordering portal for cell and gene therapies, through its Advanced Therapy Solutions business. Ordering cell and gene therapies has historically required healthcare providers to log into separate product platforms with disparate reporting structures and processes for invoicing and payment.

“A major challenge associated with cell and gene therapy ordering has been that each product has its own portal with unique log-in information, which creates a burdensome and complex process for healthcare providers,” said Fran Gregory, VP, Emerging Therapies. “We’re excited to bring this solution to market and truly simplify the ordering process for our customers so they can focus on patient care.”

Advanced Therapy Connect enables providers at treatment sites to order all available in-network cell and gene products within a single platform, reducing the administrative burden for healthcare providers. Developed with the help of provider feedback, Advanced Therapy Connect reduces manual errors and optimizes access to cell and gene therapies.

Advanced Therapy Solutions works with manufacturers to commercialize cell and gene therapies, with services that span regulatory consulting, order-to-cash management, patient support services and market access strategy, as well as storage, shipping and distribution solutions through our market leading 3PL Services and Packaging Solutions business. Advanced Therapy Connect is the latest example of Cardinal Health’s continued commitment to investing in infrastructure and solutions enabling improved patient access to cell and gene therapies.

For more information, visit Advanced Therapy Solutions | Cardinal Health.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company’s customer-centric focus drives continuous improvement and leads to innovative solutions that improve people’s lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom.

Contacts

Media: Kelli Nowinsky, Kelli.Nowinsky@cardinalhealth.com and (614) 205-3073
Investors: Matt Sims, Matt.Sims@cardinalhealth.com and (614) 553-3661